Patient Opportunity R (LMORX)

NASDAQ · Mutual Fund · Delayed Price · Currency is USD
53.36
-0.02 (-0.04%)
At close: Jul 6, 2026
Fund Assets2.00B
Expense Ratio1.94%
Min. Investment$1,000
Turnover27.00%
Dividend (ttm)n/a
Dividend Yieldn/a
Dividend Growthn/a
Payout Frequencyn/a
Ex-Dividend Daten/a
Previous Close53.38
YTD Return11.59%
1-Year Return31.14%
5-Year Return25.11%
52-Week Low39.97
52-Week High53.38
Beta (5Y)1.31
Holdings36
Inception DateDec 28, 2006

About LMORX

Patient Opportunity Trust Class R is a mutual fund structured with a flexible, value-oriented equity approach that emphasizes long-term capital growth. Managed by Patient Capital Management, the fund employs an opportunistic and contrarian investment philosophy, targeting undervalued opportunities across market cycles rather than following broader market trends. The fund is actively managed, maintaining a high active share of over 97%, which means its portfolio holdings significantly diverge from standard benchmarks like the S&P 500, offering diversification for investors seeking alternatives to traditional index exposure. The fund typically invests in a concentrated portfolio, with around 38 holdings, and spans various sectors, focusing primarily on mid-cap value equities. It may also allocate assets to debt securities of any credit quality, including high-yield bonds, to capitalize on a wider set of opportunities. The management team, led by an experienced portfolio manager, seeks to maximize returns by identifying companies and securities with compelling long-term growth prospects. With assets totaling approximately $1.3 billion and a moderate turnover rate, the fund aims to deliver sustained value over time for long-term-oriented investors.

Fund Family Patient Capital Management
Category Mid-Cap Value
Performance Rating Below Average
Risk Rating High
Stock Exchange NASDAQ
Ticker Symbol LMORX
Share Class Class R
Index S&P 500 TR

Performance

LMORX had a total return of 31.14% in the past year, including dividends. Since the fund's inception, the average annual return has been 7.39%.

Equivalent Funds

These are funds that follow the same index from the other major fund companies.

SymbolProviderNameExpense Ratio
FIQCXFidelityFidelity Advisor Asset Manager 85% Z0.56%
FBRNXFidelityFidelity Advisor Stock Sel I0.54%
FSSKXFidelityFidelity Stock Selec-Class K0.42%
FSJHXFidelityFidelity Advisor Stock Sel M1.04%
FEYAXFidelityFidelity Advisor Asset Manager 85% A0.92%

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

SymbolShare ClassExpense Ratio
MVISXClass Is1.33%
LMNOXClass I1.39%
LGOAXClass A1.69%
LMOFXClass Fi1.74%

Top 10 Holdings

53.42% of assets
NameSymbolWeight
Royalty Pharma plcRPRX6.91%
Citigroup Inc.C6.54%
Alphabet Inc.GOOGL6.30%
QXO, Inc.QXO5.60%
Amazon.com, Inc.AMZN5.46%
NVIDIA CorporationNVDA5.02%
UnitedHealth Group IncorporatedUNH4.68%
Energy Transfer LPET4.67%
IAC IncIAC4.15%
Norwegian Cruise Line Holdings Ltd.NCLH4.09%
View More Holdings